Settlement

J&J sales up, but earnings wiped out by settlements, product liability and recall costs

January 24, 2012

Days after a $158 million settlement of charges that its Janssen unit fraudulently marketed Risperdal in Texas, Johnson & Johnson forecast fourth-quarter net earnings of just $218 million due to settlement costs and the recall of its DePuy ASR artificial hip.
 

Merck wraps up Vioxx litigation with feds, states: $1b in fines, new CIA

November 22, 2011

Seven years after the biggest drug safety scandal since thalidomide was found to cause birth defects, Merck and the Justice Department announced a nearly $1 billion settlement of litigation over Vioxx, the Cox-2 pain drug found to cause strokes and heart attacks.
 

GSK hopes $3-bil. off-label settlement will end legal woes

November 07, 2011

GlaxoSmithKline's deal to resolve multiple US investigations into its sales and marketing practices—one of the largest settlements by a pharma company—aims to patch up several long-running legal disputes.
 

GSK values drive flips rep bonus incentives

January 25, 2011

The drug industry must move from a mindset that emphasizes compliance with regulations to one steeped in core values of integrity and transparency if it is to regain the public's trust, GSK's Dierdre Connelly said at a conference yesterday.
 

Company news: GlaxoSmithKline

January 18, 2011

GlaxoSmithKline said it will take a fourth-quarter legal charge of about $3.5 billion to cover the cost of a government investigation into its sales and marketing practices, as well as future product-liability cases related to diabetes drug Avandia.
 

Ruling in FTC-Watson case may sway pay-for-delay debate in Senate

July 19, 2010

A US magistrate judge ruled that the Federal Trade Commission overstepped its authority when the agency tried to pressure a generic drug company to enter into a business deal with a competitor.
 

AstraZeneca settles Seroquel off-label suit for $520m, CIA

April 27, 2010

AstraZeneca agreed to pay $520 million and enter a five-year Corporate Integrity Agreement to settle a federal case against the company for off-label marketing of Seroquel, the Departments of Justice and Health and Human Services' Healthcare Enforcement Action Team announced.
 

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
 

MM&M Awards 2011 HIghlights

The Best MM&M Awards Ever!

MAHF Ceremony 2012

Photos from the Medical Advertising Hall of Fame Awards ceremony
 
Popular Topics
Acquisition Adherence Advertising App Celebrity Clinical Trial Co-Marketing Diabetes Diagnostics Digital Direct To Consumer (DTC) Disease Awareness Downsize DTC Education & Awareness FDA Food FTC Government Guidance Health Plans HMOs Hospitals Marketing Research Sales Force